Report Categories
View AllRecent Articles
View All
Why Broadridge BR could be the anchor your portfolio needs On the Radar 20260505
PYXS Pyxis Oncology beats Q4 2025 loss estimates but shares shed 235 percent amid weak investor reaction
How Spectrum SPB manages tail risk exposure Spectrum posts 706 percent EPS beat over analyst estimates
LPSN LivePerson shares surge despite massive earnings miss and revenue decline investors upbeat on turnaround prospects